Clinigen Group plc Director/PDMR Shareholding (5835C)

TIDMCLIN

RNS Number : 5835C

Clinigen Group plc

01 October 2018

1 October 2018

PDMR SHAREHOLDINGS

Further to the Result of Placing announcement on Thursday 27 September 2018 regarding the placing of 9,467,456 new ordinary shares (the "Placing Shares"), Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Company') announces the following PDMR dealings in accordance with Article 19 of the Market Abuse Regulation:

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 
 1     Details of the person discharging managerial 
        responsibilities/person closely associated 
 a)    Name                      Shaun Chilton 
      ------------------------  ------------------------------------- 
 2     Reason for the notification 
      --------------------------------------------------------------- 
 a)    Position/status           Chief Executive Officer 
      ------------------------  ------------------------------------- 
 b)    Initial notification      Initial Notification 
        /Amendment 
      ------------------------  ------------------------------------- 
 3     Details of the issuer, emission allowance market 
        participant, auction platform, auctioneer or 
        auction monitor 
      --------------------------------------------------------------- 
 a)    Name                      Clinigen Group plc 
      ------------------------  ------------------------------------- 
 b)    Legal Entity              213800OBIKGI2JYYS227 
        Identifier 
      ------------------------  ------------------------------------- 
 4     Details of the transaction(s): section to be 
        repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and 
        (iv) each place where transactions have been 
        conducted 
      --------------------------------------------------------------- 
 a)    Description               Ordinary shares of 0.1 pence each 
        of the financial          GB00B89J2419 
        instrument, 
        type of instrument 
        Identification 
        code 
      ------------------------  ------------------------------------- 
 b)    Nature of the             Director participation in Placing 
        transaction 
      ------------------------  ------------------------------------- 
 c)    Currency                  GBP 
      ------------------------  ------------------------------------- 
 d)    Price(s) and                    Price(s)           Volume(s) 
        volume(s) 
      ------------------------  ----------------------  ------------- 
                     845p per share                         7,101 
  ----------------------------------------------------  ------------- 
 
 e)    Aggregated                 7,101 
        information 
   - Aggregated               845p 
    volume 
   - Price                    GBP60,003.45 
   - Aggregated 
    total 
 ------------------------------------------------  ------------------ 
 f)    Date of the               1 October 2018 
        transaction 
      ------------------------  ------------------------------------- 
 g)    Place of the              London Stock Exchange, AIM 
        transaction 
      ------------------------  ------------------------------------- 
 
 
 1     Details of the person discharging managerial 
        responsibilities/person closely associated 
 a)    Name                      Anne Hyland 
      ------------------------  ------------------------------------- 
 2     Reason for the notification 
      --------------------------------------------------------------- 
 a)    Position/status           Non-Executive Director 
      ------------------------  ------------------------------------- 
 b)    Initial notification      Initial Notification 
        /Amendment 
      ------------------------  ------------------------------------- 
 3     Details of the issuer, emission allowance market 
        participant, auction platform, auctioneer or 
        auction monitor 
      --------------------------------------------------------------- 
 a)    Name                      Clinigen Group plc 
      ------------------------  ------------------------------------- 
 b)    Legal Entity              213800OBIKGI2JYYS227 
        Identifier 
      ------------------------  ------------------------------------- 
 4     Details of the transaction(s): section to be 
        repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and 
        (iv) each place where transactions have been 
        conducted 
      --------------------------------------------------------------- 
 a)    Description               Ordinary shares of 0.1 pence each 
        of the financial          GB00B89J2419 
        instrument, 
        type of instrument 
        Identification 
        code 
      ------------------------  ------------------------------------- 
 b)    Nature of the             Director participation in Placing 
        transaction 
      ------------------------  ------------------------------------- 
 c)    Currency                  GBP 
      ------------------------  ------------------------------------- 
 d)    Price(s) and                    Price(s)           Volume(s) 
        volume(s) 
      ------------------------  ----------------------  ------------- 
                     845p per share                         4,142 
  ----------------------------------------------------  ------------- 
 
 e)    Aggregated                 4,142 
        information 
   - Aggregated               845p 
    volume 
   - Price                    GBP34,999.90 
   - Aggregated 
    total 
 ------------------------------------------------  ------------------ 
 f)    Date of the               1 October 2018 
        transaction 
      ------------------------  ------------------------------------- 
 g)    Place of the              London Stock Exchange, AIM 
        transaction 
      ------------------------  ------------------------------------- 
 

-Ends-

Contact Details

 
 Clinigen Group plc                             Tel: [phone] 
                                                 010 
 Shaun Chilton, Group Chief Executive 
  Officer 
  Martin Abell, Group Chief Financial 
  Officer 
  Matt Parrish, Head of Investor Relations 
 
 Numis Securities Limited                       Tel: [phone] 
 Michael Meade / Freddie Barnfield (Nominated 
  Adviser) 
  James Black / Tom Ballard (Corporate 
  Broking) 
 
 RBC Capital Markets - Joint Broker             Tel: [phone] 
 Marcus Jackson / Elliot Thomas 
 
 Instinctif Partners                            Tel: [phone] 
 Adrian Duffield / Melanie Toyne-Sewell 
  / Alex Shaw                                   Email: [e-mail] 
 

About Clinigen Group

Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and services company with a unique combination of businesses focused on providing ethical access to medicines. Its mission is to deliver the right medicine to the right patient at the right time through three areas of global medicine supply; clinical trial, unlicensed and licensed medicines. Clinigen acquired Quantum Pharma in November 2017.

For more information, please visit www.clinigengroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHLLFFSIDLLIIT

(END) Dow Jones Newswires

October 01, 2018 10:29 ET (14:29 GMT)